Cargando…

Breath biomarkers in idiopathic pulmonary fibrosis: a systematic review

BACKGROUND: Exhaled biomarkers may be related to disease processes in idiopathic pulmonary fibrosis (IPF) however their clinical role remains unclear. We performed a systematic review to investigate whether breath biomarkers discriminate between patients with IPF and healthy controls. We also assess...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hayton, Conal, Terrington, Dayle, Wilson, Andrew M., Chaudhuri, Nazia, Leonard, Colm, Fowler, Stephen J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329167/ https://www.ncbi.nlm.nih.gov/pubmed/30634961 http://dx.doi.org/10.1186/s12931-019-0971-8

Ejemplares similares

Nintedanib in the management of idiopathic pulmonary fibrosis: clinical trial evidence and real-world experience
por: Rivera-Ortega, Pilar, et al.
Publicado: (2018)

Idiopathic Pulmonary Fibrosis (IPF): An Overview
por: Barratt, Shaney L., et al.
Publicado: (2018)

Transbronchial Lung Cryobiopsy in Idiopathic Pulmonary Fibrosis: A State of the Art Review
por: Lodhi, Taha, et al.
Publicado: (2019)

Real World Experiences: Pirfenidone and Nintedanib are Effective and Well Tolerated Treatments for Idiopathic Pulmonary Fibrosis
por: Hughes, Gareth, et al.
Publicado: (2016)

Drug-Induced Interstitial Lung Disease: A Systematic Review
por: Skeoch, Sarah, et al.
Publicado: (2018)

The therapy of idiopathic pulmonary fibrosis: what is next?
por: Somogyi, Vivien, et al.
Publicado: (2019)

The detection, assessment and clinical evolution of interstitial lung abnormalities identified through lung cancer screening
por: Balata, Haval, et al.
Publicado: (2023)

Real-World Study Analysing Progression and Survival of Patients with Idiopathic Pulmonary Fibrosis with Preserved Lung Function on Antifibrotic Treatment
por: Noor, Saba, et al.
Publicado: (2020)

IPF Care: A Support Program for Patients with Idiopathic Pulmonary Fibrosis Treated with Pirfenidone in Europe
por: Duck, Annette, et al.
Publicado: (2015)

Real world experience of response to pirfenidone in patients with idiopathic pulmonary fibrosis: a two centre retrospective study
por: Eaden, James A., et al.
Publicado: (2020)

Docosatetraenoyl LPA is elevated in exhaled breath condensate in idiopathic pulmonary fibrosis
por: Montesi, Sydney B, et al.
Publicado: (2014)

Perceptions, experiences and needs of patients with idiopathic pulmonary fibrosis
por: Duck, Annette, et al.
Publicado: (2015)

Idiopathic pulmonary fibrosis in the UK: analysis of the British Thoracic Society electronic registry between 2013 and 2019
por: Spencer, Lisa G., et al.
Publicado: (2021)

Management of Septated Malignant Pleural Effusions
por: Banka, Radhika, et al.
Publicado: (2018)

A 31-year-old female with  a rare cause of recurrent lower lobar collapses
por: Banka, Radhika, et al.
Publicado: (2018)

Blood Biomarkers in Idiopathic Pulmonary Fibrosis
por: Guiot, Julien, et al.
Publicado: (2017)

Biomarkers of cellular senescence in idiopathic pulmonary fibrosis
por: Aversa, Zaira, et al.
Publicado: (2023)

Beware Weakening the Ivory Tower of MDT Diagnosis in Interstitial Lung Disease
por: Chaudhuri, Nazia, et al.
Publicado: (2019)

Test-retest repeatability for fatigue assessment scale, short-form 6-dimension and King’s sarcoidosis questionnaire in people with sarcoidosis associated fatigue
por: Ferris, Rebecca, et al.
Publicado: (2023)

Macrophage-Derived Biomarkers of Idiopathic Pulmonary Fibrosis
por: Bargagli, E., et al.
Publicado: (2011)

Home spirometry in patients with idiopathic pulmonary fibrosis: data from the INMARK trial
por: Noth, Imre, et al.
Publicado: (2021)

Tissue is an issue in the search for biomarkers in idiopathic pulmonary fibrosis
por: Kaarteenaho, Riitta, et al.
Publicado: (2015)

Importance of serial changes in biomarkers in idiopathic pulmonary fibrosis
por: Sokai, Akihiko, et al.
Publicado: (2017)

Sputum exosomes: promising biomarkers for idiopathic pulmonary fibrosis
por: Njock, Makon-Sébastien, et al.
Publicado: (2019)

Evaluation of oxidative stress biomarkers in idiopathic pulmonary fibrosis and therapeutic applications: a systematic review
por: Fois, Alessandro G., et al.
Publicado: (2018)

Aerobic and breathing exercises improve dyspnea, exercise capacity and quality of life in idiopathic pulmonary fibrosis patients: systematic review and meta-analysis
por: Hanada, Masatoshi, et al.
Publicado: (2020)

Serum AGE/RAGEs as potential biomarker in idiopathic pulmonary fibrosis
por: Machahua, Carlos, et al.
Publicado: (2018)

The usefulness of monomeric periostin as a biomarker for idiopathic pulmonary fibrosis
por: Ohta, Shoichiro, et al.
Publicado: (2017)

GDF15 is an epithelial-derived biomarker of idiopathic pulmonary fibrosis
por: Zhang, Yingze, et al.
Publicado: (2019)

On Target: CYFRA 21-1 as an Idiopathic Pulmonary Fibrosis Biomarker
por: Spagnolo, Paolo, et al.
Publicado: (2022)

Potential biomarkers for diagnosis and disease evaluation of idiopathic pulmonary fibrosis
por: Wang, Qing, et al.
Publicado: (2023)

Idiopathic pulmonary fibrosis
por: Meltzer, Eric B, et al.
Publicado: (2008)

Idiopathic Pulmonary Fibrosis
por: Lynch, Joseph P., et al.
Publicado: (2011)

Exploring the Role of Biomarkers Associated with Alveolar Damage and Dysfunction in Idiopathic Pulmonary Fibrosis—A Systematic Review
por: Zamfir, Alexandra-Simona, et al.
Publicado: (2023)

Acupuncture for idiopathic pulmonary fibrosis: Protocol for a systematic review
por: Xie, Yang, et al.
Publicado: (2017)

Classification of Tidal Breathing Airflow Profiles Using Statistical Hierarchal Cluster Analysis in Idiopathic Pulmonary Fibrosis
por: Williams, E. Mark, et al.
Publicado: (2018)

Systematic review of content and quality of idiopathic pulmonary fibrosis review articles
por: Milne, Kathryn M., et al.
Publicado: (2018)

Mortality and survival in idiopathic pulmonary fibrosis: a systematic review and meta-analysis
por: Zheng, Qiang, et al.
Publicado: (2022)

Matrix metalloproteinase-10: a novel biomarker for idiopathic pulmonary fibrosis
por: Sokai, Akihiko, et al.
Publicado: (2015)

Identification of the lipid biomarkers from plasma in idiopathic pulmonary fibrosis by Lipidomics
por: Yan, Feng, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_01kk73clfh0kql8f77cubtgc3h